APIE Therapeutics Provides Evidence that Activating the Apelinergic System can Repair and Regenerate...
APIE Therapeutics Provides Evidence that Activating the Apelinergic System can Repair and Regenerate Lung Tissue Damaged by Pulmonary Fibrosis: Presentation at IPF Summit Elucidates APT-101 Mechanism of Action
About this item
Full title
APIE Therapeutics Provides Evidence that Activating the Apelinergic System can Repair and Regenerate Lung Tissue Damaged by Pulmonary Fibrosis: Presentation at IPF Summit Elucidates APT-101 Mechanism of Action
Publisher
New York: NASDAQ OMX Corporate Solutions, Inc
Journal title
NASDAQ OMX's News Release Distribution Channel, 2022
Language
English
Formats
Publication information
Publisher
New York: NASDAQ OMX Corporate Solutions, Inc
Subjects
More information
Alternative Titles
Full title
APIE Therapeutics Provides Evidence that Activating the Apelinergic System can Repair and Regenerate Lung Tissue Damaged by Pulmonary Fibrosis: Presentation at IPF Summit Elucidates APT-101 Mechanism of Action
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_2707825972
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2707825972
How to access this item
Log in as a Library member
